Second‐line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records

por Lal, Lincy S., Said, Qayyim, Andrade, Katherine, Cuker, Adam
Publicado 2020

Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis

por Doleh, Yunes, Lal, Lincy S., Blauer‐Petersen, Cori, Antico, Giovanni, Pishvaian, Michael
Publicado 2020

Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer...

por Mudad, Raja, Patel, Manish B, Margunato-Debay, Sandra, Garofalo, David, Lal, Lincy S
Publicado 2017

Managing Specialty Medication Services Through a Specialty Pharmacy Program: The Case of Oral Renal Transplant Immunosuppressant Medications

por Tschida, Suzanne, Aslam, Saad, Khan, Tanvir T., Sahli, Brett, Shrank, William H., Lal, Lincy S.
Publicado 2013

Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study

por Lal, Lincy S., Aly, Abdalla, Le, Lisa B., Peckous, Susan, Seal, Brian, Teitelbaum, April
Publicado 2021

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

por Schwartzberg, Lee S, Lal, Lincy S, Balu, Sanjeev, Campbell, Kim, Brekke, Lee, Elliott, Caitlin, Korrer, Stephanie
Publicado 2018

Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis

por Patwardhan, Pallavi, Landsteiner, Adrienne, Lal, Lincy S., Geevarghese, Lincy, Le, Lisa, Nandal, Savita, Cuker, Adam
Publicado 2021

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

por Jin, Ran, Ogbomo, Adesuwa S., Accortt, Neil A., Lal, Lincy S., Bishi, Geetanjali, Sandschafer, Darcie, Goldschmidt, Jerome H.
Publicado 2023

Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis

por Aslam, Saad, Li, Edward, Bell, Elizabeth, Lal, Lincy, Anderson, Amy J, Peterson-Brandt, Jesse, Lyman, Gary
Publicado 2023

Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing Chemotherapy

por Schwartzberg, Lee S., Lal, Lincy S., Balu, Sanjeev, Campbell, Kim, Brekke, Lee, DeLeon, Andrew, Elliott, Caitlin, Korrer, Stephanie
Publicado 2018

Informal science, technology, engineering and math learning conditions to increase parent involvement with young children experiencing poverty

por Zucker, Tricia A., Maldonado, Gloria Yeomans, Assel, Michael, McCallum, Cheryl, Elias, Cindy, Swint, John M., Lal, Lincy
Publicado 2022

Geographic Variation in Medication Adherence in Commercial and Medicare Part D Populations

por Couto, Joseph E., Panchal, Janki M., Lal, Lincy S., Bunz, Thomas J., Maesner, Jon E., O’Brien, Terrence, Khan, Tanvir
Publicado 2014

Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis

por Karpes Matusevich, Aliza R, Lal, Lincy S, Chan, Wenyaw, Swint, J Michael, Cantor, Scott B, Suarez-Almazor, Maria E, Lopez-Olivo, Maria A
Publicado 2021

The evaluation of comprehensive medication management for chronic diseases in primary care clinics, a Texas delivery system reform incentive payment program

por Chung, Tong Han, Hernandez, Ricardo J., Libaud-Moal, Anaelle, Nguyen, Linh K., Lal, Lincy S., Swint, J. Michael, Lansangan, Pio Juan, Le, Yen-Chi L.
Publicado 2020

The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors

por George, Saby, Bell, Elizabeth J., Zheng, Ying, Kim, Ruth, White, John, Devgan, Geeta, Smith, Jodi, Lal, Lincy S., Engel‐Nitz, Nicole M., Liu, Frank X.
Publicado 2021

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

por Voong, K. Ranh, Lal, Lincy S., Kuban, Deborah A., Pugh, Thomas J., Swint, J. Michael, Godby, Joy, Choi, Seungtaek, Lee, Andrew K., Schlembach, Pamela J., Frank, Steven J., McGuire, Sean E., Hoffman, Karen E.
Publicado 2017